1. Home
  2. RYZ vs PHAR Comparison

RYZ vs PHAR Comparison

Compare RYZ & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation Common Stock

RYZ

Ryerson Holding Corporation Common Stock

N/A

Current Price

$26.61

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.67

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYZ
PHAR
Founded
1842
1988
Country
United States
Netherlands
Employees
4300
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
RYZ
PHAR
Price
$26.61
$12.67
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
333.3K
10.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$75.79
$10.04
Revenue Next Year
$2.17
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$19.34
$9.54
52 Week High
$29.03
$21.34

Technical Indicators

Market Signals
Indicator
RYZ
PHAR
Relative Strength Index (RSI) 53.96 31.19
Support Level $23.60 $11.43
Resistance Level $29.03 $17.41
Average True Range (ATR) 1.38 0.53
MACD -0.17 -0.09
Stochastic Oscillator 56.10 15.28

Price Performance

Historical Comparison
RYZ
PHAR

About RYZ Ryerson Holding Corporation Common Stock

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: